网络发育因子 网络释义 1. 发育因子 聚乙二醇化重组人巨核细胞生长及发育因子(PEG-rHuMGDF)是一种与天然重组人血小板生成素不同的异体蛋白。在对PEG-rHu… mall.cnki.net|基于2个网页
PEG-rHuMGDF Dictionary, Encyclopedia and Thesaurus - The Free Dictionary13,675,804,789visits served TheFreeDictionary Google ? Keyboard Word / Article Starts with Ends with Text EnglishEspañolDeutschFrançaisItalianoالعربية中文简体PolskiPortuguêsNederlandsNorskΕλληνικήРу...
摘要: 临床前研究表明,PEG-rHuMGDF(pegylated recombinant human megakaryocyte growth and development factor)是巨核细胞集落形成和血小板产生的一种有效刺激剂,可望用于重度血小板减少症的治疗.为测定其临床效能和安全性,对晚期癌症病人化疗前用PEG-rHuMGDF的结果进行了评估. 17例晚期癌症病人,Karnofsky状况60%或以上...
The role of transforming growth factor-beta in PEG-rHuMGDF-induced reversible myelofibrosis in rats. British Journal of Haematology 1997; 99:739-745.Yanagida M, Ide Y, Imai A, Toriyama M, Aoki T, Harada K, Izumi H, Uzumaki H, Kusaka M, Tokiwa T. The role of transforming growth factor...
Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHUMGDF) in patients with advanced cancerdoi:10.1016/S0140-6736(96)04471-6SummaryBackground Pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) is a potent stimulator of ...
Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in patients with advanced cancer SummaryBackground Pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) is a potent stimulator of megakaryocyte colony form... ...
Basser RL,Rasko JE,Clarke K,et al.Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in patients with advanced cancer. The Lancet . 1996Basser RL, Rasko JE, Clarke K et al. Thrombopoietic effects of pegylated recombinant human ...
Involvement of the TGF-β1 Derived from Megakaryocyte in the PEG-rHuMGDF-Induced Myelofibrosis and Bone Formation Yasuko Namiki1 et al.Invol- vement of the TGF-β1 derived from Megakaryocyte in the PEG-rHuMGDF-Induced Myelofibrosis and bone formati- on.J Toxicol ... Y Ide,E Yamanaka,Y ...
ICE dose intensity was improved with PEG-rHuMGDF versus placebo: 75 versus 42% (P = 0.008). At 8.5 years median follow-up, overall and event-free survival are 47 and 31%, respectively. Patients treated on PEG-rHuMGDF versus placebo had improved survival (59 versus 31%, P = 0.06). ...
The use of PEG-rHuMGDF in platelet apheresis. Kuter DJ. Stem Cells(Dayt) . 1998Kuter DJ. The use of PEG-rhuMGDF in platelet apheresis. Stem Cells 1998; 16: 231–242.Kuter DJ. The use of PEG-rhuMGDF in platelet apheresis. Stem Cells. 1998;16:231–42....